chronic
obstruct
pulmonari
diseas
copd
defin
presenc
progress
incomplet
revers
obstruct
lung
diseas
diffus
caus
includ
chronic
bronchiti
emphysema
small
airway
diseas
approxim
patient
present
annual
exacerb
copd
admit
intens
care
unit
icu
ventilatori
assist
either
bilevel
noninvas
posit
pressur
ventil
niv
ventil
via
endotrach
tube
ett
despit
sever
studi
unventil
popul
two
studi
ventil
copd
patient
viral
aetiolog
mani
copd
exacerb
remain
unclear
respiratori
virus
shown
caus
upper
lower
respiratori
tract
infect
via
inflammatori
neural
mediat
influenza
type
b
inf
b
parainfluenza
type
para
rhinoviru
rv
adenoviru
av
respiratori
syncyti
viru
rsv
coronaviru
cov
less
commonli
human
metapneumoviru
hmpv
enteroviru
ev
shown
play
signific
role
airway
infect
hypothesis
viral
infect
may
associ
signific
diseas
burden
patient
exacerb
copd
admit
icu
ventilatori
support
aim
investig
incid
virus
also
sought
known
biolog
atyp
pathogen
respons
copd
exacerb
build
complet
microbiolog
profil
possibl
patient
age
year
requir
mechan
ventil
exacerb
copd
within
h
admiss
hospit
consid
studi
patient
admit
icu
ventilatori
support
defin
copd
baselin
predict
incomplet
revers
obstruct
spirometri
per
american
thorac
societi
european
respiratori
atser
copd
consensu
guidelin
absenc
prior
spirometri
assess
smoke
histori
least
pack
year
physic
examin
review
previou
hospit
record
chest
radiograph
chang
suggest
copd
exclus
major
comorbid
primari
caus
chronic
breathless
chronic
reduct
exercis
toler
make
diagnosi
copd
icu
admiss
ventilatori
support
consid
despit
optim
medic
therapi
oxygen
administr
acidosi
ph
hypercapnia
mmhg
increas
respiratori
distress
andor
worsen
fatigu
reduc
conscious
decis
mechan
ventil
made
attend
icu
specialist
base
upon
past
histori
current
clinic
radiolog
inform
patient
assess
either
niv
endotrach
intub
use
guidelin
british
thorac
societi
patient
exclud
studi
elect
mechan
ventil
mechan
ventil
expect
surviv
due
sever
underli
copd
concurr
ill
consult
either
capabl
consciou
relativescar
giver
patient
asthma
complet
revers
bronchodil
less
year
old
restrict
lung
diseas
surgeri
trauma
within
previou
week
admit
gener
ward
icu
admiss
h
therefor
risk
hospitalacquir
infect
exclud
presenc
clinic
pneumonia
find
chest
radiograph
chang
exclud
patient
viru
infect
well
recognis
caus
pneumon
chang
studi
conduct
juli
novemb
approv
studi
obtain
hospit
ethic
committe
consent
obtain
patient
nextofkin
durat
prodrom
symptom
increas
cough
worsen
dyspnoea
increas
quantiti
discolour
sputum
increas
wheez
estim
start
symptomat
deterior
prior
smoke
histori
exercis
toler
baselin
function
capabl
presenc
comorbid
record
treatment
prior
hospit
admiss
list
includ
home
oxygen
corticosteroid
therapi
antibiot
previou
day
baselin
clinic
paramet
blood
result
apach
ii
score
arteri
blood
ga
prior
commenc
mechan
ventil
note
everi
effort
made
exclud
caus
respiratori
failur
respiratori
depress
uncontrol
oxygen
therapi
pulmonari
embol
increas
atmospher
pollut
acut
left
ventricular
failur
pneumothorax
use
care
histori
take
clinic
acumen
radiolog
angiographi
echocardiographi
appropri
full
blood
count
chemistri
blood
cultur
chest
radiographi
perform
admiss
hospit
sputum
specimen
collect
admiss
possibl
within
h
hospit
admiss
viral
nasal
pharyng
specimen
taken
patient
stabilis
enrol
studi
sputum
bacteri
analysi
collect
via
endotrach
tube
suction
intub
patient
spontan
voluntari
cough
patient
receiv
niv
specimen
collect
ident
nasopharyng
aspir
npa
posterior
pharyng
swab
ps
copan
venturi
transystem
itali
collect
patient
immunofluoresc
assay
ifa
either
direct
merifluor
bioscienc
cincinnati
ohio
indirect
chemicon
intern
temecula
ca
viru
cultur
vc
perform
npa
viru
cultur
perform
ps
polymeras
chain
reaction
pcr
specimen
patient
routin
treat
bronchodil
empir
antibiot
least
day
chang
ceas
accord
subsequ
microbiolog
profil
patient
receiv
physiotherapi
clinic
stabl
new
chest
radiograph
chang
admiss
impli
pneumon
chang
collaps
present
previou
chest
film
avail
clearli
abnorm
hallmark
primari
pulmonari
patholog
process
whether
chang
new
chronic
agre
consensu
thorac
physician
intensivist
defin
probabl
pathogen
like
biolog
agent
caus
exacerb
copd
acut
serolog
titr
inf
b
para
rsv
av
chlamydia
legionella
mycoplasma
antibodi
follow
week
later
pair
convalesc
titr
fourfold
rise
titr
signifi
probabl
caus
agent
viru
nucleic
acid
extract
without
revers
transcriptas
amplif
perform
npa
ps
sampl
pcr
detect
perform
inf
b
para
rsv
type
b
hexaplex
assay
human
ev
hmpv
cov
rv
av
realtim
pcr
appendix
electron
supplementari
materi
esm
contain
detail
posit
pcr
viral
assay
consid
evid
probabl
viru
pathogen
screen
genusspecif
chlamydia
assay
igg
iga
initi
perform
purpos
studi
seroconvers
either
igg
iga
acut
convalesc
sera
consid
evid
acut
chlamydia
genu
infect
singl
acut
convalesc
specimen
either
iga
iga
igg
present
indic
probabl
recent
infect
chlamydia
posit
igg
without
iga
consid
evid
recent
chlamydia
infect
sputum
process
perform
use
standard
laboratori
media
microscopi
gram
stain
smear
well
identif
signific
isol
report
sputum
sampl
consid
nonrepres
lower
respiratori
tract
specimen
fewer
neutrophil
per
highpow
field
squamou
epitheli
cell
per
lowpow
field
signific
cultur
result
base
qualiti
sputum
whether
cultur
match
smear
result
identifi
bacteria
defin
probabl
pathogen
predomin
growth
potenti
respiratori
pathogen
obtain
presenc
gram
stain
microscopi
show
profus
organ
consist
morphotyp
bacteri
isol
consid
commens
improb
pathogen
statist
analysi
perform
use
r
version
wwwrprojectorg
categor
variabl
analys
use
chisquar
test
fisher
exact
test
appropri
depend
whether
number
conting
tabl
satisfi
chisquar
test
assumpt
continu
variabl
analys
use
utest
nonnorm
distribut
variabl
unpair
ttest
normal
distribut
variabl
p
valu
consid
signific
potenti
particip
potenti
episod
total
enter
studi
follow
reason
particip
declin
death
inclus
enrol
h
hospit
admiss
failur
meet
criteria
diagnosi
copd
two
patient
admit
twice
separ
episod
three
patient
includ
studi
without
hypercarbia
mmhg
indic
niv
case
combin
hypoxia
spite
adequ
oxygen
therapi
ph
symptomat
relief
patient
episod
die
within
day
admiss
mean
apach
ii
score
rang
tabl
less
patient
recent
premorbid
spirometri
valu
data
therefor
omit
report
convalesc
serolog
followup
initi
viral
atyp
titr
unabl
obtain
sputum
specimen
suitabl
bacteri
analysi
patient
episod
patient
receiv
niv
probabl
infecti
aetiolog
found
episod
viru
probabl
pathogen
case
sole
organ
case
tabl
part
mix
infect
case
tabl
viru
cultur
herp
simplex
viru
type
posit
case
six
case
also
anoth
probabl
pathogen
identifi
remain
two
distinguish
clinic
radiolog
featur
identifi
hsv
probabl
pathogen
eight
result
therefor
includ
probabl
pathogen
two
viral
cultur
posit
one
inf
one
rv
correl
posit
pcr
inf
common
organ
case
rv
cov
hmpv
ev
twentyfour
episod
occur
australian
summer
autumn
month
decemb
may
whilst
bulk
exacerb
occur
winter
spring
month
june
novemb
p
figur
show
season
breakdown
two
discret
cluster
influenza
occur
within
period
earli
spring
separ
year
compris
influenza
aposit
case
pattern
cluster
infect
type
probabl
bacteri
aetiolog
found
case
tabl
sole
agent
case
mix
infect
tabl
haemophilu
influenza
common
bacterium
case
chlamydia
speci
atyp
organ
found
sole
aetiolog
case
mix
infect
mix
infect
constitut
case
tabl
statist
signific
differ
group
probabl
viral
aetiolog
without
viral
aetiolog
length
prodrom
initi
clinic
paramet
apach
ii
score
chang
chest
radiograph
length
stay
mortal
tabl
two
publish
seri
infect
agent
ventil
copd
patient
subsequ
studi
also
examin
outcom
treatment
one
initi
seri
patient
soler
studi
fagon
studi
intub
facilit
protect
brush
bronchoalveolar
lavag
specimen
bronchoscop
specimen
collect
perform
smaller
subset
intub
patient
studi
patient
receiv
niv
alon
receiv
niv
ett
intub
without
niv
collect
appropri
respiratori
sampl
complic
introduct
niv
accept
modal
treatment
sever
copd
exacerb
niv
patient
may
produc
suitabl
sputum
fibreopt
bronchoscopi
may
easili
toler
patient
spite
use
modifi
face
mask
induc
sputum
specimen
hyperton
salin
although
effect
method
sampl
collect
unintub
patient
may
induc
worsen
bronchospasm
consid
practic
option
cohort
initi
respiratori
instabl
bacteria
grown
sputum
endotrach
aspir
may
repres
pathogen
organ
caus
exacerb
half
stabl
copd
patient
colonis
potenti
bacteri
pathogen
reduc
possibl
examin
sputum
specimen
presenc
neutrophil
correl
gram
stain
cultur
effort
determin
whether
organ
commens
probabl
pathogen
twentyf
patient
receiv
antibiot
within
day
prior
icu
admiss
posit
bacteri
cultur
h
influenza
possibl
recent
antibiot
therapi
may
reduc
bacteri
yield
episod
must
consid
soler
fagon
focus
primarili
bacteri
yield
fagon
investig
virus
soler
obtain
serolog
chlamydia
mycoplasma
legionella
inf
para
rsv
hsv
av
hmpv
cov
ev
rv
sought
soler
found
potenti
pathogen
case
compar
studi
communityacquir
bacteria
case
cohort
studi
fagon
found
bacteria
protect
brush
specimen
predominantli
haemophilu
streptococcu
speci
soler
find
signific
clinic
outcom
differ
bacteriaposit
neg
group
whilst
fagon
note
significantli
greater
pyrexia
present
bacteriaposit
group
paramet
protect
brush
specimen
may
well
increas
overal
yield
bacteria
whilst
ensur
falseposit
rate
minimis
limit
rang
virus
sought
lack
pcr
assay
may
well
underrepres
viru
incid
soler
studi
compar
found
atyp
organ
case
compar
adequ
followup
serolog
survivor
studi
may
account
pauciti
proven
atyp
organ
case
polymicrobi
soler
studi
compar
mechan
viral
upper
respiratori
tract
infect
urti
caus
lower
respiratori
tract
infect
lrti
symptom
includ
cytokin
paracrin
releas
alter
cellmedi
immun
lymphocyt
recruit
neurohormon
reflex
direct
epitheli
damag
lower
respiratori
tract
may
therefor
assum
recoveri
common
virus
upper
respiratori
tract
sampl
npa
ps
reflect
probabl
viral
aetiolog
lower
respiratori
tract
symptom
lower
sensit
viral
diagnosi
direct
bronchoscop
sampl
lower
respiratori
tract
specimen
possibl
viru
aetiolog
implic
nonventil
copd
exacerb
case
common
viru
detect
seri
vari
due
season
variat
method
viru
detect
influenza
vaccin
statu
infa
rsv
cov
rv
frequent
detect
viral
pathogen
recent
studi
copd
exacerb
studi
inf
para
rsv
rv
often
detect
tabl
one
studi
suggest
patient
evid
viru
infect
copd
exacerb
greater
symptom
sever
onset
nonviru
exacerb
significantli
longer
median
time
symptom
recoveri
find
studi
signific
differ
prodrom
symptom
length
icu
hospit
stay
mortal
observ
viru
nonviru
exacerb
studi
first
use
pcr
detect
virus
ventil
copd
patient
pcr
sensit
method
viru
detect
viru
cultur
least
sensit
garbino
report
viru
cultur
posit
bronchoalveolar
lavag
bal
specimen
group
hospitalis
patient
lrti
whilst
revers
transcriptas
pcr
rtpcr
identifi
viru
specimen
may
presenc
small
quantiti
viru
detect
cultur
viral
pathogen
difficult
cultur
h
ill
pcr
abl
detect
infect
longer
period
due
high
sensit
pcr
consist
associ
high
detect
rate
studi
copd
exacerb
popul
viru
yield
rise
antibodi
titr
week
consid
strong
evid
probabl
viru
atyp
pathogen
obvious
possibl
deceas
patient
lost
followup
whilst
use
epidemiolog
tool
provid
retrospect
diagnosi
therefor
affect
clinic
decis
critic
unwel
use
new
genet
techniqu
enhanc
diagnost
yield
provid
accur
pictur
role
viral
infect
see
appendix
esm
howev
case
diagnos
rtpcr
alon
heavi
relianc
rtpcr
establish
diagnosi
viral
infect
may
sensit
detect
small
amount
residu
viral
nucleic
acid
without
clinic
evid
viral
infect
extens
precaut
taken
contamin
studi
neg
pcr
control
show
evid
fals
posit
respiratori
virus
may
commens
stabl
copd
patient
seemung
found
respiratori
virus
often
sputum
nasal
lavag
patient
exacerb
copd
patient
stabl
copd
latent
sequenc
common
respiratori
virus
adenoviru
detect
pcr
well
demonstr
copd
patient
may
excret
rsv
extend
period
time
one
absolut
certain
rsv
demonstr
studi
necessarili
pathogen
virus
persist
colonis
well
describ
reason
assum
play
pathogen
role
quantit
realtim
pcr
may
allow
differenti
latent
former
infect
current
infect
advanc
avail
rapid
molecular
sequenc
may
also
allow
chang
infecti
agent
serotyp
antibiot
resist
discern
evid
date
suggest
treatment
antivir
agent
subset
copd
patient
viru
exacerb
requir
ventilatori
support
significantli
alter
cours
acut
ill
nevertheless
import
better
understand
pattern
diseas
order
target
effici
potenti
treatment
earli
detect
viru
infect
pcr
infanc
develop
sophist
antivir
agent
may
allow
earli
target
viru
pathogen
probabl
viru
pathogen
found
case
probabl
bacteri
aetiolog
found
case
studi
ventil
copd
exacerb
patient
prodrom
initi
clinic
paramet
distinguish
viral
nonvir
ill
studi
signific
differ
viru
nonviru
exacerb
ventil
timelength
stay
mortal
niv
made
protect
specimen
collect
difficult
intub
patient
may
decreas
bacteri
viral
yield
pcr
offer
detail
view
spectrum
viru
ill
group
patient
includ
previous
unsought
virus
ev
hmpv
